Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Mejd Jumaily, Farhoud Faraji & Joseph D. Brunworth. (2016) Endoscopic orbital exenteration in the treatment of acute invasive fungal sinusitis. Acta Oto-Laryngologica Case Reports 1:1, pages 58-62.
Read now
Read now
Joerg J. Vehreschild, Andrea Birtel, Maria J. G. T. Vehreschild, Blasius Liss, Fedja Farowski, Matthias Kochanek, Michal Sieniawski, Angela Steinbach, Kerstin Wahlers, Gerd Fätkenheuer & Oliver A. Cornely. (2013) Mucormycosis treated with posaconazole: review of 96 case reports. Critical Reviews in Microbiology 39:3, pages 310-324.
Read now
Read now
A.M. Picco, P. Angelini, C. Ciccarone, A. Franceschini, A. Ragazzi, M. Rodolfi, G.C. Varese & M. Zotti. (2011) Biodiversity of emerging pathogenic and invasive fungi in plants, animals and humans in Italy. Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology 145:4, pages 988-996.
Read now
Read now
Morena Caira, Enrico Maria Trecarichi, Mario Mancinelli, Giuseppe Leone & Livio Pagano. (2011) Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment. Expert Review of Anti-infective Therapy 9:7, pages 881-892.
Read now
Read now
Jörg J Vehreschild, Maria JGT Rüping, Angela Steinbach & Oliver A Cornely. (2010) Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients. Expert Opinion on Pharmacotherapy 11:1, pages 95-113.
Read now
Read now
Articles from other publishers (65)
Dhiraj Bhambhani, Garima Bhambhani, Shaji Thomas, Suresh Bhambhani, Swapnil Parlani & Riddhi Tandon. (2023) Comparison Between Pre-COVID and Post-COVID Mucormycosis: A Systematic Review and Meta-analysis. Journal of Maxillofacial and Oral Surgery.
Crossref
Crossref
Bharti Sharma & Skarma Nonzom. (2023) Mucormycosis and Its Upsurge During COVID-19 Epidemic: An Updated Review. Current Microbiology 80:10.
Crossref
Crossref
Souvagini Acharya, Sulin K Behera, Somy Purohit, Alaka Sahu, Braja B Panda & Sharmistha Behera. (2023) COVID-19-Associated Rhino-Orbital Mucormycosis in a Tertiary Health Care Center in Odisha, India. Cureus.
Crossref
Crossref
Fatima Allaw, Johnny Zakhour, Sarah B. Nahhal, Karim Koussa, Elio R. Bitar, Anthony Ghanem, Martine Elbejjani & Souha S. Kanj. (2023) Mucormycosis: A 14-Year Retrospective Study from a Tertiary Care Center in Lebanon. Journal of Fungi 9:8, pages 824.
Crossref
Crossref
Frederic Lamoth. (2023) Novel Approaches in the Management of Mucormycosis. Current Fungal Infection Reports 17:2, pages 98-107.
Crossref
Crossref
Maria Drogari-Apiranthitou, Anna Skiada, Ioannis Panayiotides, Timoleon-Achilleas Vyzantiadis, Aikaterina Poulopoulou, Myrto Christofidou, Anastasia Antoniadou, Emmanuel Roilides, Elias Iosifidis, Vassiliki Mamali, Athina Argyropoulou, Styliani Sympardi, Nikoletta Charalampaki, Nikolaos Antonakos, Paraskevi Mantzana, Zafeiria Mastora, Ourania Nicolatou-Galitis, Maria Orfanidou, Zoi-Dorothea Pana, Ioannis Pavleas, Angelos Pefanis, Vissaria Sakka, Anastasia Spiliopoulou, Maria Stamouli, Polydoros Tofas, Eleni Vagiakou & George Petrikkos. (2023) Epidemiology of Mucormycosis in Greece; Results from a Nationwide Prospective Survey and Published Case Reports. Journal of Fungi 9:4, pages 425.
Crossref
Crossref
Ronen Ben-Ami. (2023) Systemic Antifungal Therapy for Invasive Pulmonary Infections. Journal of Fungi 9:2, pages 144.
Crossref
Crossref
Nadeem Rais, Rizwan Ahmad, Akash Ved, Kehkashan Parveen, Darakhshan Gazala Bari & Om Prakash. (2023) Diabetic Ketoacidosis (DKA), a Leading Risk Factor for Mucormycosis
(Black Fungus), during the Era of Coronavirus Disease-2019 (COVID-19):
An Overview. Current Diabetes Reviews 19:1.
Crossref
Crossref
Sudipta Chakraborty & Sailee Chowdhury. 2023. Viral, Parasitic, Bacterial, and Fungal Infections. Viral, Parasitic, Bacterial, and Fungal Infections
309
321
.
Thomas F. Patterson, Nathan P. Wiederhold & Connie F. Cañete-Gibas. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1272
1274.e2
.
Yayue Zhang, Anita H. Sung, Emily Rubinstein, Michael Benigno, Richard Chambers, Nataly Patino & Jalal A. Aram. (2022) Characterizing patients with rare mucormycosis infections using real-world data. BMC Infectious Diseases 22:1.
Crossref
Crossref
Hassan Almarhabi, Essam Al-Asmari, Adeeb Munshi, Fayssal Farahat, Abdulfatah Al-Amri, Hatim Q. Almaghraby, Maher Alharbi & Abulhakeem Althaqafi. (2022) Invasive mucormycosis in a tertiary care hospital in the western region of Saudi Arabia: 11-year retrospective chart review from 2009 to 2019. Journal of Infection and Public Health 15:12, pages 1466-1471.
Crossref
Crossref
Md. Rezaul Islam, Md. Mominur Rahman, Md. Tanjimul Ahasan, Nadia Sarkar, Shopnil Akash, Mahfuzul Islam, Fahadul Islam, Most. Nazmin Aktar, Mohd Saeed, Md. Harun-Or-Rashid, Md. Kawsar Hosain, Md. Saidur Rahaman, Sadia Afroz, Shabana Bibi, Md. Habibur Rahman & Sherouk Hussein Sweilam. (2022) The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance. Environmental Science and Pollution Research 29:46, pages 69341-69366.
Crossref
Crossref
Reshma P. Chavan, Shivraj M. Ingole, Hamna Abdul Nazir, Wilson V. Desai & Gajanan S. Kanchewad. (2022) Mucormycosis in COVID-19 pandemic: study at tertiary hospital in India. European Archives of Oto-Rhino-Laryngology 279:6, pages 3201-3210.
Crossref
Crossref
Raúl Parra Fariñas, Montserrat Alonso‐Sardón, Virginia Velasco‐Tirado, Inmaculada Galindo Pérez, Cristina Carbonell, Elisa Álvarez Artero, Ángela Romero‐Alegría, Javier Pardo‐Lledías & Moncef Belhassen‐García. (2022) Increasing Incidence of mucormycosis in Spanish inpatients from 1997 to 2018. Mycoses 65:3, pages 344-353.
Crossref
Crossref
Sumel Ashique. (2022) 'Mucormycosis': A Fungal Infection Threatening India During
COVID-19' - A Review. Anti-Infective Agents 20:1.
Crossref
Crossref
MohanBilikallahalli Sannathimmappa, Vinod Nambiar & Rajeev Aravindakshan. (2022) Storm of a rare opportunistic life threatening mucormycosis among post COVID-19 patients: A tale of two pathogens. International Journal of Critical Illness and Injury Science 12:1, pages 38.
Crossref
Crossref
Salman Hussain, Abanoub Riad, Ambrish Singh, Jitka Klugarová, Benny Antony, Hasanul Banna & Miloslav Klugar. (2021) Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis. Journal of Fungi 7:11, pages 985.
Crossref
Crossref
Michael A. Pfaller, Cecilia G. Carvalhaes, Shawn A. Messer, Paul R. Rhomberg & Mariana Castanheira. (2021) In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years. Diagnostic Microbiology and Infectious Disease 101:3, pages 115473.
Crossref
Crossref
Rupa Mehta, Nitin M. Nagarkar, Atul Jindal, Karthik Nagaraja Rao, S. B. Nidhin, Ripu Daman Arora, Anil Sharma, Archana Wankhede, Satish Satpute, Sharmistha Chakravarty, N. K. Agrawal, Pranita, Pankaj Kannauje, Ajoy Behera & Pugazhenthan Thangaraju. (2021) Multidisciplinary Management of COVID-Associated Mucormycosis Syndemic in India. Indian Journal of Surgery.
Crossref
Crossref
Ram Kumar Sahu, Mounir M. Salem-Bekhit, Bedanta Bhattacharjee, Yosif Almoshari, Abu Md Ashif Ikbal, Meshal Alshamrani, Alakesh Bharali, Ahmad Salawi, Retno Widyowati, Abdulrahman Alshammari & Ibrahim Elbagory. (2021) Mucormycosis in Indian COVID-19 Patients: Insight into Its Patho-Genesis, Clinical Manifestation, and Management Strategies. Antibiotics 10:9, pages 1079.
Crossref
Crossref
María Teresa Martín Gómez & Miguel Salavert Lletí. (2021) Mucormicosis: perspectiva de manejo actual y de futuro. Revista Iberoamericana de Micología 38:2, pages 91-100.
Crossref
Crossref
Priya Uppuluri, Abdullah Alqarihi & Ashraf S. Ibrahim. 2021. Encyclopedia of Mycology. Encyclopedia of Mycology
600
612
.
Frédéric Lamoth. 2021. Infection Management in Hematology. Infection Management in Hematology
1
12
.
Anna Skiada, Ioannis Pavleas & Maria Drogari-Apiranthitou. (2020) Epidemiology and Diagnosis of Mucormycosis: An Update. Journal of Fungi 6:4, pages 265.
Crossref
Crossref
Jannik Stemler, Kamal Hamed, Jon Salmanton‐García, Ali Rezaei‐Matehkolaei, Stefanie K. Gräfe, Ertan Sal, Marouan Zarrouk, Danila Seidel, Reham Abdelaziz Khedr, Ronen Ben‐Ami, Eli Ben‐Chetrit, Yehudah Roth & Oliver A. Cornely. (2020)
Mucormycosis in the Middle East and North Africa: Analysis of the FungiScope
®
registry and cases from the literature
. Mycoses 63:10, pages 1060-1068.
Crossref
Crossref
Alison G. Freifeld & Daniel R. Kaul. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
544
564.e6
.
Oliver A Cornely, Ana Alastruey-Izquierdo, Dorothee Arenz, Sharon C A Chen, Eric Dannaoui, Bruno Hochhegger, Martin Hoenigl, Henrik E Jensen, Katrien Lagrou, Russell E Lewis, Sibylle C Mellinghoff, Mervyn Mer, Zoi D Pana, Danila Seidel, Donald C Sheppard, Roger Wahba, Murat Akova, Alexandre Alanio, Abdullah M S Al-Hatmi, Sevtap Arikan-Akdagli, Hamid Badali, Ronen Ben-Ami, Alexandro Bonifaz, Stéphane Bretagne, Elio Castagnola, Methee Chayakulkeeree, Arnaldo L Colombo, Dora E Corzo-León, Lubos Drgona, Andreas H Groll, Jesus Guinea, Claus-Peter Heussel, Ashraf S Ibrahim, Souha S Kanj, Nikolay Klimko, Michaela Lackner, Frederic Lamoth, Fanny Lanternier, Cornelia Lass-Floerl, Dong-Gun Lee, Thomas Lehrnbecher, Badre E Lmimouni, Mihai Mares, Georg Maschmeyer, Jacques F Meis, Joseph Meletiadis, C Orla Morrissey, Marcio Nucci, Rita Oladele, Livio Pagano, Alessandro Pasqualotto, Atul Patel, Zdenek Racil, Malcolm Richardson, Emmanuel Roilides, Markus Ruhnke, Seyedmojtaba Seyedmousavi, Neeraj Sidharthan, Nina Singh, János Sinko, Anna Skiada, Monica Slavin, Rajeev Soman, Brad Spellberg, William Steinbach, Ban Hock Tan, Andrew J Ullmann, Jörg J Vehreschild, Maria J G T Vehreschild, Thomas J Walsh, P Lewis White, Nathan P Wiederhold, Theoklis Zaoutis & Arunaloke Chakrabarti. (2019) Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. The Lancet Infectious Diseases 19:12, pages e405-e421.
Crossref
Crossref
Frederic Lamoth & Dimitrios P. Kontoyiannis. (2019)
Therapeutic Challenges of Non-
Aspergillus
Invasive Mold Infections in Immunosuppressed Patients
. Antimicrobial Agents and Chemotherapy 63:11.
Crossref
Crossref
Brandon S. Walker, Robert L. Schmidt, Srinivas Tantravahi, Kibum Kim & Kimberly E. Hanson. (2019) Cost‐effectiveness of antifungal prophylaxis, preemptive therapy, or empiric treatment following allogeneic hematopoietic stem cell transplant. Transplant Infectious Disease 21:5.
Crossref
Crossref
Marcio Nucci, Marc Engelhardt & Kamal Hamed. (2019) Mucormycosis in South America: A review of 143 reported cases. Mycoses 62:9, pages 730-738.
Crossref
Crossref
Hariprasath Prakash & Arunaloke Chakrabarti. (2019) Global Epidemiology of Mucormycosis. Journal of Fungi 5:1, pages 26.
Crossref
Crossref
Alexandra Serris, François Danion & Fanny Lanternier. (2019) Disease Entities in Mucormycosis. Journal of Fungi 5:1, pages 23.
Crossref
Crossref
Brad Spellberg & Johan Maertens. 2019. Principles and Practice of Transplant Infectious Diseases. Principles and Practice of Transplant Infectious Diseases
577
589
.
Jun Feng & Xuefeng Sun. (2018) Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome. Infection 46:4, pages 503-512.
Crossref
Crossref
Thomas F. Patterson & Deanna A. Sutton. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1247
1250.e1
.
Ryan Kronen, Stephen Y. Liang, Grant Bochicchio, Kelly Bochicchio, William G. Powderly & Andrej Spec. (2017) Invasive Fungal Infections Secondary to Traumatic Injury. International Journal of Infectious Diseases 62, pages 102-111.
Crossref
Crossref
Reza Samarei, Naser Gharebaghi & Salar Zayer. (2017) Evaluation of 30 cases of mucormycosis at a university hospital in Iran. Mycoses 60:7, pages 426-432.
Crossref
Crossref
Matteo Bassetti & Emilio Bouza. (2017) Invasive mould infections in the ICU setting: complexities and solutions. Journal of Antimicrobial Chemotherapy 72:suppl_1, pages i39-i47.
Crossref
Crossref
José Moreira, Andrea Varon, Maria Clara Galhardo, Fabio Santos, Marcelo Lyra, Rodolfo Castro, Raquel Oliveira & Cristiane C. Lamas. (2016) The burden of mucormycosis in HIV-infected patients: A systematic review. Journal of Infection 73:3, pages 181-188.
Crossref
Crossref
Afsane Vaezi, Maryam Moazeni, Mohammad Taghi Rahimi, Sybren de Hoog & Hamid Badali. (2016) Mucormycosis in Iran: a systematic review. Mycoses 59:7, pages 402-415.
Crossref
Crossref
M. Schmidt-Hieber, G. Silling, E. Schalk, W. Heinz, J. Panse, O. Penack, M. Christopeit, D. Buchheidt, U. Meyding-Lamadé, S. Hähnel, H.H. Wolf, M. Ruhnke, S. Schwartz & G. Maschmeyer. (2016) CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)—Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Annals of Oncology 27:7, pages 1207-1225.
Crossref
Crossref
Su Jin Jeong, Ji Un Lee, Young Goo Song, Kyoung Hwa Lee & Min Joo Lee. (2015) Delaying diagnostic procedure significantly increases mortality in patients with invasive mucormycosis. Mycoses 58:12, pages 746-752.
Crossref
Crossref
Martin Schmidt-Hieber. 2015. Infections in Hematology. Infections in Hematology
211
226
.
Nikolay N. Klimko, Sofya N. Khostelidi, Alisya G. Volkova, Marina O. Popova, Tatyana S. Bogomolova, Ludmila S. Zuborovskaya, Aleksey S. Kolbin, Nadezhda V. Medvedeva, Ilya S. Zuzgin, Sergey M. Simkin, Nataliya V. Vasilyeva & Boris V. Afanasiev. (2014) Mucormycosis in haematological patients: case report and results of prospective study in Saint Petersburg, Russia. Mycoses 57:s3, pages 91-96.
Crossref
Crossref
Arunaloke Chakrabarti & Rachna Singh. (2014) Mucormycosis in India: unique features. Mycoses 57:s3, pages 85-90.
Crossref
Crossref
G. Petrikkos, A. Skiada & M. Drogari-Apiranthitou. (2014) Epidemiology of mucormycosis in Europe. Clinical Microbiology and Infection 20, pages 67-73.
Crossref
Crossref
O.A. Cornely, S. Arikan-Akdagli, E. Dannaoui, A.H. Groll, K. Lagrou, A. Chakrabarti, F. Lanternier, L. Pagano, A. Skiada, M. Akova, M.C. Arendrup, T. Boekhout, A. Chowdhary, M. Cuenca-Estrella, T. Freiberger, J. Guinea, J. Guarro, S. de Hoog, W. Hope, E. Johnson, S. Kathuria, M. Lackner, C. Lass-Flörl, O. Lortholary, J.F. Meis, J. Meletiadis, P. Muñoz, M. Richardson, E. Roilides, A.M. Tortorano, A.J. Ullmann, A. van Diepeningen, P. Verweij & G. Petrikkos. (2014) ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clinical Microbiology and Infection 20, pages 5-26.
Crossref
Crossref
Carlos Rodrigo Camara-Lemarroy, Emmanuel Irineo González-Moreno, René Rodríguez-Gutiérrez, Erick Joel Rendón-Ramírez, Ana Sofía Ayala-Cortés, Martha Lizeth Fraga-Hernández, Laura García-Labastida & Dionicio Ángel Galarza-Delgado. (2014) Clinical Features and Outcome of Mucormycosis. Interdisciplinary Perspectives on Infectious Diseases 2014, pages 1-5.
Crossref
Crossref
Russell E. Lewis, Sarah P. Georgiadou, Fotis Sampsonas, George Chamilos & Dimitrios P. Kontoyiannis. (2014) Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis. Mycoses 57:1, pages 49-55.
Crossref
Crossref
Alison G. Freifeld & Daniel R. Kaul. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
562
580.e5
.
A. Candoni, M. Caira, S. Cesaro, A. Busca, M. Giacchino, R. Fanci, M. Delia, A. Nosari, A. Bonini, C. Cattaneo, L. Melillo, C. Caramatti, G. Milone, R. Scime’, M. Picardi, R. Fanin & L. Pagano. (2013) Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real-life combo study. Mycoses, pages n/a-n/a.
Crossref
Crossref
Sherif M. Zaki, Iman M. Elkholy, Nadia A. Elkady & Khayria. Abdel-Ghany. (2013) Mucormycosis in Cairo, Egypt: review of 10 reported cases. Medical Mycology, pages 1-8.
Crossref
Crossref
Yasuki Uchida, Mitsuhiro Tsukino, Wataru Shigemori, Eiichi Hayashi, Isao Watanabe, Takahisa Nakayama, Eiji Yamada & Kunihiro Moro. (2012) Diagnosis of pulmonary mucormycosis aiding the diagnosis of small cell lung cancer. Journal of Medical Microbiology 61:11, pages 1610-1613.
Crossref
Crossref
F. Lanternier, H.-Y. Sun, P. Ribaud, N. Singh, D. P. Kontoyiannis & O. Lortholary. (2012) Mucormycosis in Organ and Stem Cell Transplant Recipients. Clinical Infectious Diseases 54:11, pages 1-8.
Crossref
Crossref
F. Lanternier, E. Dannaoui, G. Morizot, C. Elie, D. Garcia-Hermoso, M. Huerre, D. Bitar, F. Dromer & O. Lortholary. (2012) A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007). Clinical Infectious Diseases 54:suppl 1, pages S35-S43.
Crossref
Crossref
George Petrikkos, Anna Skiada, Olivier Lortholary, Emmanuel Roilides, Thomas J. Walsh & Dimitrios P. Kontoyiannis. (2012) Epidemiology and Clinical Manifestations of Mucormycosis. Clinical Infectious Diseases 54:suppl_1, pages S23-S34.
Crossref
Crossref
Giulia Morace & Elisa Borghi. (2012)
Invasive Mold Infections: Virulence and Pathogenesis of
Mucorales
. International Journal of Microbiology 2012, pages 1-5.
Crossref
Crossref
Thomas F. Patterson & Deanna A. Sutton. 2012. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1212
1215.e2
.
Sarah P. Hammond, Lindsey R. Baden & Francisco M. Marty. (2011) Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis, 2001 to 2009. Antimicrobial Agents and Chemotherapy 55:11, pages 5018-5021.
Crossref
Crossref
Michele D. Mignogna, Giulio Fortuna, Stefania Leuci, Daniela Adamo, Elvira Ruoppo, Maria Siano & Umberto Mariani. (2011) Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature. International Journal of Infectious Diseases 15:8, pages e533-e540.
Crossref
Crossref
Andreu Llorente, Ignacio Perez-Valero, E. García, I. Heras, V. Fraile, P. García, J. López, M. Salavert & F. Bobillo. (2011) Mortality risk factors in patients with zygomycosis: a retrospective and multicentre study of 25 cases. Enfermedades Infecciosas y Microbiología Clínica 29:4, pages 263-268.
Crossref
Crossref
Brad Spellberg & Ashraf S. Ibrahim. (2010) Recent Advances in the Treatment of Mucormycosis. Current Infectious Disease Reports 12:6, pages 423-429.
Crossref
Crossref
Hsin-Yun Sun, Graeme Forrest, Krishan L. Gupta, Jose M. Aguado, Olivier Lortholary, Marino Blanes Julia, Nasia Safdar, Robin Patel, Shimon Kusne & Nina Singh. (2010) Rhino-Orbital-Cerebral Zygomycosis in Solid Organ Transplant Recipients. Transplantation 90:1, pages 85-92.
Crossref
Crossref
M. J. G. T. Ruping, W. J. Heinz, A. J. Kindo, V. Rickerts, C. Lass-Florl, C. Beisel, R. Herbrecht, Y. Roth, G. Silling, A. J. Ullmann, K. Borchert, G. Egerer, J. Maertens, G. Maschmeyer, A. Simon, M. Wattad, G. Fischer, J. J. Vehreschild & O. A. Cornely. (2009) Forty-one recent cases of invasive zygomycosis from a global clinical registry. Journal of Antimicrobial Chemotherapy 65:2, pages 296-302.
Crossref
Crossref